|
Volumn 50, Issue 6, 2009, Pages 1474-1476
|
FDA perspective on objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
CATHETER;
ECONOMIC ASPECT;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE ORGANIZATION;
HEART ASSIST DEVICE;
LIMB ISCHEMIA;
MARKETING;
MEDICAL INSTRUMENTATION;
METHODOLOGY;
PRIORITY JOURNAL;
UNITED STATES;
ADVISORY COMMITTEES;
CATHETERIZATION, PERIPHERAL;
CONTROLLED CLINICAL TRIALS AS TOPIC;
CRITICAL ILLNESS;
DEVICE APPROVAL;
EQUIPMENT DESIGN;
EQUIPMENT SAFETY;
EVIDENCE-BASED MEDICINE;
EXTREMITIES;
HUMANS;
ISCHEMIA;
PRACTICE GUIDELINES AS TOPIC;
RESEARCH DESIGN;
RISK ASSESSMENT;
RISK FACTORS;
SOCIETIES, MEDICAL;
TREATMENT OUTCOME;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
VASCULAR SURGICAL PROCEDURES;
|
EID: 70649086971
PISSN: 07415214
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jvs.2009.09.045 Document Type: Article |
Times cited : (30)
|
References (6)
|